SEC Form 4 · accession 0001209191-16-148238
PharMerica CORP · PMC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geoffrey G Meyers
Director
Period of report
Oct 31, 2016
Accepted (ET)
Nov 3, 2016 · 5:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001388195
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, $0.01 par value | Oct 31, 2016 | M | 29,268 | $15.06 | A | 72,943 | D | |
| Common Stock, $0.01 par value | Oct 31, 2016 | F | 18,520 | $23.80 | D | 54,423 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Options (Right to Buy)F1 | $15.06 | Oct 31, 2016 | M | 29,268 | D | — | Nov 17, 2016 | Common Stock, $.01 par value | 29,268 | 0 | D |
Explanation of responses
- F1The options vested as follows: 9,756 options on 11/17/2010, 9,756 options on 11/17/2011 and 9,756 options on 11/17/2012.